Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies

Clinical trial NCT00061620 · COMPLETED

Trial details

NCT number: NCT00061620
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2001-09-06
Primary completion: 2004-02-12
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.